| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-25 | Samsara BioCapital, L.P. | LEAP THERAPEUTICS, INC. | 2,442,352 | 6.4% | EDGAR |
| SC 13G | 2024-04-19 | GILEAD SCIENCES, INC. | LEAP THERAPEUTICS, INC. | 5,319,148 | 13.9% | EDGAR |
| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | LEAP THERAPEUTICS, INC. | 1,068,497 | 4.0% | EDGAR |
| SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | LEAP THERAPEUTICS, INC. | 6,726,496 | 6.8% | EDGAR |
| SC 13G/A | 2022-02-15 | PERCEPTIVE ADVISORS LLC | LEAP THERAPEUTICS, INC. | 8,476,496 | 9.6% | EDGAR |
| SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | LEAP THERAPEUTICS, INC. | - | 0.0% | EDGAR |
| SC 13G/A | 2022-02-11 | Artal International S.C.A. | LEAP THERAPEUTICS, INC. | 4,000,000 | 4.5% | EDGAR |
| SC 13G/A | 2022-02-10 | ELI LILLY & Co | LEAP THERAPEUTICS, INC. | 3,151,605 | 3.5% | EDGAR |
| SC 13D/A | 2021-09-29 | BeiGene, Ltd. | LEAP THERAPEUTICS, INC. | 12,153,074 | 13.2% | EDGAR |
| SC 13G/A | 2021-02-16 | Artal International S.C.A. | LEAP THERAPEUTICS, INC. | 3,000,000 | 5.0% | EDGAR |
| SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | LEAP THERAPEUTICS, INC. | 8,476,496 | 14.2% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | LEAP THERAPEUTICS, INC. | 3,716,240 | 6.2% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | LEAP THERAPEUTICS, INC. | 606,000 | 1.0% | EDGAR |
| SC 13G | 2020-12-28 | Artal International S.C.A. | LEAP THERAPEUTICS, INC. | 3,000,000 | 5.0% | EDGAR |
| SC 13G | 2020-04-20 | PERCEPTIVE ADVISORS LLC | LEAP THERAPEUTICS, INC. | 6,726,496 | 18.8% | EDGAR |
| SC 13D | 2020-03-23 | BeiGene, Ltd. | LEAP THERAPEUTICS, INC. | 9,609,274 | 23.7% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | LEAP THERAPEUTICS, INC. | 1,266,800 | 5.1% | EDGAR |
| SC 13D/A | 2020-01-21 | Valence Helix Investments III, LLC | LEAP THERAPEUTICS, INC. | 1,906,060 | 7.5% | EDGAR |
| SC 13D | 2019-02-15 | Valence Helix Investments III, LLC | LEAP THERAPEUTICS, INC. | 2,251,428 | 9.6% | EDGAR |
| SC 13G/A | 2019-02-14 | LILLY ELI & CO | LEAP THERAPEUTICS, INC. | 2,632,221 | 17.9% | EDGAR |